Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMGEN INC Director's Dealing 2012

Oct 23, 2012

29819_dirs_2012-10-23_4f1659fd-e6b5-40c8-85f2-c2db34b9114a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-10-22

Reporting Person: Patton Cynthia M (SVP & CCO)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7554 Direct
Common Stock 48.9635 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Nqso (Right to Buy) $50.44 2016-04-28 Common Stock (900) Direct
Nqso (Right to Buy) $58.43 2020-04-26 Common Stock (1840) Direct
Nqso (Right to Buy) $54.69 2021-04-25 Common Stock (5225) Direct

Footnotes

F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 129 RSUs which fully vest on 4/28/2013; 263 RSUs which vest in two installments of 131 and 132 on 4/26/2013 and 4/26/2014, respectively; 3,000 RSUs which vest in three equal annual installments of 1,000 each commencing 10/28/2012; 1,493 RSUs which vest in three installments of 492, 493 and 508 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,200 RSUs which vest in two equal installments of 396 each on 4/27/2014 and 4/27/2015 and one installment of 408 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2: These shares include 11 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

F3: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.

F4: These stock options are exercisable in two equal annual installments of 920 each commencing on 4/26/2013.

F5: These stock options are exercisable in two annual installments of 1,724 each on 4/25/2013 and 4/25/2014 and one installment of 1,777 on 4/25/2015.